Despite limited clinical evidence, all available data suggest that intradermal administration of the Bavarian Nordic-produced Jynneos® vaccine will be as immunogenic as subcutaneous dosing for preventing monkeypox infection and illness, which leads us to favor intradermal use from both the individual and public health perspectives, wrote a group of vaccine experts.
'Vaccines work only if they are accessible, trusted, and used.'
Monkeypox Intradermal Vaccination Offers Several Benefits
Menstrual Cycle Disrupted by COVID-19 Vaccination
Early in 2022, a study funded by the U.S. National Institutes of Health (NIH) found women receiving one dose of a COVID-19 vaccine during a single menstrual cycle had an increase in cycle length of nearly one day.
Recently, a large international study funded by the NIH confirmed those findings linking COVID-19 vaccination with an average increase in menstrual cycle length of less than one day.
For most study participants, the increase resolved in the cycle following vaccination.